Sigyn Therapeutics, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

CONVERTIBLE PROMISSORY DEBENTURES (Details Narrative)

CONVERTIBLE PROMISSORY DEBENTURES (Details Narrative) - USD ($)									1 Months Ended			12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Apr. 10, 2024	Apr. 09, 2024	Jan. 08, 2024	Dec. 31, 2023	Dec. 31, 2022	Jan. 28, 2020	Sep. 30, 2024	Jun. 30, 2024	May 31, 2024	Dec. 31, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Cash	$ 2,085,895											$ 2,085,895
Aggregate numbers of warrants to purchase shares						559,839							559,839
Debt conversion amount												$ 707,730	$ 1,520,200
Debt conversion, shares issued												157,526
Convertible note	1,891,736					$ 2,210,299						$ 1,891,736	2,210,299
Debt discount	707,730											707,730
Original issue discount	12,384					49,489						12,384	49,489
2024 Convertible Notes Four [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount	879,029											879,029
Cash	$ 795,890											$ 795,890
Debt instrument maturity date	January and June 2025 based on $1.00 for each $0.90909 paid by the noteholders and
Term of warrants	5 years											5 years
Aggregate numbers of warrants to purchase shares	219,758											219,758
Exercise price of warrants per share	$ 6.00											$ 6.00
Proceeds from issuance of convertible debt	$ 795,890
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	$ 83,139											$ 83,139
Debt instrument conversion price per share	$ 4.00											$ 4.00
Debt conversion amount									$ 474,794	$ 232,937	$ 232,937
Debt conversion, shares issued									118,700	38,826	38,826
Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible note					$ 44,000
Maturity date					Jan. 08, 2025
2023 Convertible Notes Three [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount						294,400							294,400
Cash						$ 240,000							$ 240,000
Debt instrument maturity date						July 2024 through March 2025 based on $1.00 for each $0.90909 paid by the noteholders and
Term of warrants						5 years							5 years
Aggregate numbers of warrants to purchase shares						66,000							66,000
Exercise price of warrants per share						$ 7.50							$ 7.50
Proceeds from issuance of convertible debt						$ 240,000
Debt instrument conversion price per share						$ 4.00							$ 4.00
Maturity date		Aug. 31, 2025		Mar. 31, 2025
Debt discount						$ 54,400							$ 54,400
Original issue discount		$ 15,400		$ 15,000					$ 15,400
2022 Convertible Notes Two [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount							$ 935,735
Cash							$ 700,000
Debt instrument maturity date			August 2024 and March 2025				January 2024 through December 7, 2024 based on $1.00 for each $0.90909 paid by the previous noteholder and
Term of warrants							5 years
Aggregate numbers of warrants to purchase shares							192,500
Exercise price of warrants per share							$ 7.50
Proceeds from issuance of convertible debt							$ 770,000
Debt instrument conversion price per share							$ 4.00
Maturity date		Aug. 31, 2025
Original issue discount		$ 56,306	$ 41,350				$ 70,000		56,306
Convertible Promissory Note One [Member] \| Osher Capital Partners LLC [Member]
Short-Term Debt [Line Items]
Cash	$ 350,005											$ 350,005
Maturity date												Aug. 31, 2025
Convertible Promissory Note One [Member] \| Securities Purchase Agreement [Member] \| Osher Capital Partners LLC [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount								$ 620,553
Debt instrument maturity date								August 30, 2024, based on $1.00 for each $0.90909 paid by Osher
Term of warrants								5 years
Aggregate numbers of warrants to purchase shares								102,827
Exercise price of warrants per share								$ 5.60
Proceeds from issuance of convertible debt								$ 350,005
Debt instrument conversion price per share								$ 3.76
Original issue discount		$ 56,414						$ 270,548	$ 56,414